Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem vs Meropenem + Azithromycin in Pediatric XDR Typhoid Fever
NCT07641348Not yet recruiting
- Start
- Jul 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised trial in typhoid fever comparing Meropenem Monotherapy with Meropenem + Azithromycin Combination (2 arms). Primary endpoint: Time to defervescence. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
azithromycinmeropenem
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT07641348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07641348.